S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NASDAQ:IONS

Ionis Pharmaceuticals (IONS) News Today

$46.28
+3.62 (+8.49%)
(As of 09/26/2023 ET)
Compare
Today's Range
$43.55
$46.54
50-Day Range
$38.50
$43.64
52-Week Range
$32.69
$47.74
Volume
2.68 million shs
Average Volume
1.04 million shs
Market Capitalization
$6.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$47.80
SourceHeadline
msn.com logoIonis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
msn.com - September 26 at 3:34 PM
msn.com logoIonis late-stage rare disease data fails to impress Bernstein
msn.com - September 26 at 3:34 PM
finance.yahoo.com logoIonis Climbs On Late-Stage Trial Results For Body Fat Disorder
finance.yahoo.com - September 26 at 3:34 PM
reuters.com logoIonis Pharma's genetic disorder drug succeeds in late-stage study
reuters.com - September 26 at 10:33 AM
markets.businessinsider.com logoIonis Reports Positive Results From Phase 3 Study Of Olezarsen In Familial Chylomicronemia Syndrome
markets.businessinsider.com - September 26 at 10:33 AM
reuters.com logoIonis Pharma's genetic disorder drug meets main goal in late-stage study
reuters.com - September 26 at 10:33 AM
finance.yahoo.com logoIonis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndrome
finance.yahoo.com - September 26 at 10:33 AM
finance.yahoo.com logoUPDATE 2-Ionis' metabolic disorder drug lowers high levels of a type of fat in study
finance.yahoo.com - September 26 at 10:33 AM
marketbeat.com logoArden Trust Co Reduces Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - September 24 at 6:58 AM
MarketBeat logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Recommendation of "Hold" by Analysts
americanbankingnews.com - September 21 at 2:26 AM
MarketBeat logoLeerink Partnrs Comments on Ionis Pharmaceuticals, Inc.'s Q3 2023 Earnings (NASDAQ:IONS)
americanbankingnews.com - September 21 at 1:18 AM
marketbeat.com logoQ3 2023 Earnings Forecast for Ionis Pharmaceuticals, Inc. Issued By Leerink Partnrs (NASDAQ:IONS)
marketbeat.com - September 20 at 6:07 AM
finance.yahoo.com logoIonis to host investor and analyst day event
finance.yahoo.com - September 20 at 1:29 AM
marketbeat.com logoARK Investment Management LLC Decreases Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - September 15 at 5:17 PM
marketbeat.com logoARK Investment Management LLC Decreases Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - September 15 at 5:17 PM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Acquired by BVF Inc. IL
marketbeat.com - September 12 at 4:39 AM
finance.yahoo.com logoWhy Is Ionis Pharmaceuticals (IONS) Up 1.4% Since Last Earnings Report?
finance.yahoo.com - September 8 at 4:14 PM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Bought by Rhumbline Advisers
marketbeat.com - September 7 at 4:29 AM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Consensus Recommendation of "Hold" by Analysts
marketbeat.com - August 27 at 2:18 AM
marketbeat.com logoExodusPoint Capital Management LP Reduces Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - August 25 at 11:16 AM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Russell Investments Group Ltd.
marketbeat.com - August 24 at 4:32 AM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Stock Position Decreased by Federated Hermes Inc.
marketbeat.com - August 22 at 4:38 AM
marketbeat.com logoTower Research Capital LLC TRC Boosts Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - August 21 at 5:37 AM
marketbeat.com logo15,571 Shares in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Acquired by Mirae Asset Global Investments Co. Ltd.
marketbeat.com - August 20 at 4:10 AM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.
marketbeat.com - August 18 at 6:38 AM
marketbeat.com logoQ3 2023 EPS Estimates for Ionis Pharmaceuticals, Inc. Lifted by Analyst (NASDAQ:IONS)
marketbeat.com - August 14 at 2:17 AM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Stake Lowered by Sicart Associates LLC
marketbeat.com - August 11 at 9:23 PM
finance.yahoo.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 11 at 5:42 PM
markets.businessinsider.com logoBarclays Remains a Hold on Ionis Pharmaceuticals (IONS)
markets.businessinsider.com - August 10 at 4:43 PM
msn.com logoIonis Pharmaceuticals (IONS) Reports Q2 Results: What Key Metrics Have to Say (Revised)
msn.com - August 10 at 11:32 AM
finance.yahoo.com logoQ2 2023 Ionis Pharmaceuticals Inc Earnings Call
finance.yahoo.com - August 10 at 11:32 AM
finance.yahoo.com logoIonis reports second quarter 2023 financial results
finance.yahoo.com - August 9 at 7:28 AM
seekingalpha.com logoNovartis and Ionis in pact for new cardiovascular therapy
seekingalpha.com - August 3 at 1:29 PM
finance.yahoo.com logoIonis enters collaboration to advance next generation program targeting Lp(a) for cardiovascular disease
finance.yahoo.com - August 3 at 8:28 AM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Amalgamated Bank
marketbeat.com - August 3 at 4:39 AM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Hold" from Brokerages
marketbeat.com - August 2 at 2:26 AM
cnbc.com logoThis little-known pharma stock can rally 50%, Citi says
cnbc.com - July 31 at 1:34 PM
finance.yahoo.com logoIonis completes enrollment in landmark Phase 3 CARDIO-TTRansform study in patients with TTR-mediated amyloid cardiomyopathy
finance.yahoo.com - July 31 at 8:33 AM
marketbeat.com logoPrivium Fund Management B.V. Increases Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - July 28 at 8:46 PM
finance.yahoo.com logoIonis expands eplontersen agreement with AstraZeneca to include exclusive rights in Latin America
finance.yahoo.com - July 28 at 10:24 AM
finance.yahoo.com logoIonis to hold second quarter 2023 financial results webcast
finance.yahoo.com - July 26 at 11:30 PM
marketbeat.com logoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Sumitomo Mitsui Trust Holdings Inc.
marketbeat.com - July 23 at 4:33 AM
barrons.com logoThe Fight Against Alzheimer’s Goes Beyond Plaque. Tangles Are a Target, Too.
barrons.com - July 19 at 8:04 AM
finance.yahoo.com logoBridgeBio unveils positive results from rare heart disease drug trial, shares jump
finance.yahoo.com - July 17 at 1:19 PM
marketbeat.com logoPeregrine Capital Management LLC Raises Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - July 14 at 5:51 AM
marketbeat.com logoDekaBank Deutsche Girozentrale Has $5.72 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - July 13 at 5:02 AM
marketbeat.com logoBard Financial Services Inc. Reduces Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
marketbeat.com - July 12 at 8:23 AM
markets.businessinsider.com logoAnalysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS) and RegenXBio (RGNX)
markets.businessinsider.com - July 12 at 1:46 AM
finance.yahoo.com logoIonis (IONS) Posts Encouraging Data From Amyloidosis Drug Study
finance.yahoo.com - July 11 at 3:46 PM
finance.yahoo.com logoEplontersen continued to show improvement in ATTRv-PN through 85 weeks
finance.yahoo.com - July 10 at 7:16 AM
Get Ionis Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter.



IONS Media Mentions By Week

IONS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IONS
News Sentiment

0.70

0.53

Average
Medical
News Sentiment

IONS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IONS Articles
This Week

17

4

IONS Articles
Average Week

Get Ionis Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:IONS) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -